rs2295923

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024642.5(GALNT12):​c.372-7T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00271 in 1,614,064 control chromosomes in the GnomAD database, including 170 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0032 ( 16 hom., cov: 33)
Exomes 𝑓: 0.0027 ( 154 hom. )

Consequence

GALNT12
NM_024642.5 splice_region, intron

Scores

2
Splicing: ADA: 0.7849
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.59

Publications

5 publications found
Variant links:
Genes affected
GALNT12 (HGNC:19877): (polypeptide N-acetylgalactosaminyltransferase 12) This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011]
GALNT12 Gene-Disease associations (from GenCC):
  • colorectal cancer, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 9-98823249-T-A is Benign according to our data. Variant chr9-98823249-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0691 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALNT12NM_024642.5 linkc.372-7T>A splice_region_variant, intron_variant Intron 1 of 9 ENST00000375011.4 NP_078918.3 Q8IXK2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALNT12ENST00000375011.4 linkc.372-7T>A splice_region_variant, intron_variant Intron 1 of 9 1 NM_024642.5 ENSP00000364150.3 Q8IXK2-1
GALNT12ENST00000610463.1 linkn.66-3503T>A intron_variant Intron 1 of 3 4 ENSP00000477657.1 A0A087WT76

Frequencies

GnomAD3 genomes
AF:
0.00321
AC:
488
AN:
152200
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0750
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00696
AC:
1751
AN:
251454
AF XY:
0.00647
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00434
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.0799
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000369
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00265
AC:
3879
AN:
1461746
Hom.:
154
Cov.:
32
AF XY:
0.00263
AC XY:
1912
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33476
American (AMR)
AF:
0.00416
AC:
186
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00379
AC:
99
AN:
26136
East Asian (EAS)
AF:
0.0787
AC:
3125
AN:
39696
South Asian (SAS)
AF:
0.00136
AC:
117
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53410
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000160
AC:
178
AN:
1111900
Other (OTH)
AF:
0.00273
AC:
165
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
221
442
662
883
1104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00321
AC:
489
AN:
152318
Hom.:
16
Cov.:
33
AF XY:
0.00337
AC XY:
251
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41572
American (AMR)
AF:
0.00268
AC:
41
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.0752
AC:
389
AN:
5172
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68024
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000872
Hom.:
1
Bravo
AF:
0.00416
Asia WGS
AF:
0.0230
AC:
81
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 23, 2021
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Colorectal cancer, susceptibility to, 1 Benign:1
Jan 13, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jan 15, 2025
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The splice region variant NM_024642.5(GALNT12):c.372-7T>A has been reported to ClinVar as Benign with a status of (2 stars) criteria provided, multiple submitters, no conflicts (Variation ID 416211 as of 2025-01-02). The variant is observed in one or more well-documented healthy adults. For these reasons, this variant has been classified as Benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
16
DANN
Benign
0.67
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.78
dbscSNV1_RF
Benign
0.58
SpliceAI score (max)
0.30
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.30
Position offset: 7

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295923; hg19: chr9-101585531; COSMIC: COSV66662325; API